Modi Naturals' Subsidiary Modi Biotech Secures New Ethanol Supply Orders Targeting FY27 Growth

Market snapshot: Modi Naturals' subsidiary, Modi Biotech, has reportedly secured a new ethanol supply order of ₹140 crore, bringing its cumulative order book to around ₹540 crore (as stated in the source alert; not independently verified). This development aligns with the company's continuous efforts under Joint Managing Director Akshay Modi to focus on operational efficiency and sustainable profitability for FY27 (as stated in the source alert; not independently verified).

Data Snapshot

• The company's subsidiary Modi Biotech operates a newly expanded grain-based ethanol plant in Raipur, Chhattisgarh with a total capacity of 282 KLPD, following a ₹100 crore capital expenditure program.
• Modi Naturals reported a consolidated net profit of ₹12.50 crore for the first quarter ended June 30, 2026.
• Modi Naturals is targeting consolidated revenue of ₹950 crore to ₹1,100 crore for FY27, representing a significant increase over the ₹719.2 crore recorded in FY26.

What's Changed

• The Raipur ethanol facility rised to 282 KLPD capacity from its legacy 130 KLPD capacity after completing its phase II expansion.
• Modi Naturals has shifted its primary revenue growth engine from commodity edible oils to bioenergy, targeting up to ₹1,100 crore in revenue for FY27.

Key Takeaways

• Strategic transition from thin-margin bulk edible oil business to higher-margin ethanol manufacturing is rapidly scaling up.
• Raipur facility's expanded commercial operations from March 2026 are translating into robust Q1 FY27 profitability.
• A substantial order book from OMCs secures excellent revenue visibility and capacity utilization over the next 12 months.

SAHI Perspective

Modi Naturals is executing a highly calculated structural pivot. Packing and selling consumer brands like Oleev provides steady, working-capital-light cash flows, but the ethanol business is the ultimate growth and margin multiplier. By tripling distillery capacity to 282 KLPD and securing deep contractual ties with oil marketing companies, the company is insulating itself from the extreme price volatility typical of the bulk edible oil market.

Market Implications

The continuous expansion of the ethanol blending program under government policy acts as a powerful secular tailwind. With the Supreme Court recently paving the way for an additional 149 crore litres of ethanol procurement by OMCs, the addressable market for non-LTOA and LTOA manufacturers alike has expanded. This policy stability is expected to drive re-rating across regional bioenergy players.

Trading Signals

Market Bias: Bullish

Strong near-term momentum is backed by the completion of a ₹100 crore capex program and robust Q1 FY27 consolidated net profit of ₹12.50 crore, securing solid bottom-line support.

Overweight: Biofuels, Packaged Foods, Agricultural Commodities

Underweight: Fossil Fuel Refineries

Trigger Factors:

• Fulfillment of the reported ₹400 crore OMC ethanol order book.
• Sustained elevated utilization rates at the 282 KLPD Raipur facility.
• Stabilization of raw material (broken grain/maize) prices.

Time Horizon: Medium-term (3-12 months)

Industry Context

India's national bioenergy push aims to hit high ethanol blending targets in petrol under the Ethanol Blended Petrol Programme. This regulatory drive has transformed corn, maize, and damaged grain processors into vital energy infrastructure providers, enabling players like Modi Biotech to scale rapidly and capture high-margin government tenders.

Key Risks to Watch

• Raw material price volatility of key starchy feedstocks such as maize and broken rice.
• Policy changes or pricing revisions by Oil Marketing Companies for ethanol procurement.
• Project execution and maintenance delays at the Raipur plant.

Recent Developments

In August 2026, the Supreme Court issued an interim order permitting OMCs to procure an additional 149 crore litres of ethanol under the Quarter IV tender of ESY 2025-26. This legal resolution was passed in a batch of petitions led by Modi Biotech, paving the way for equal treatment of suppliers and unlocking massive volume opportunities for the company.

Closing Insight

Modi Naturals represents a classic corporate transformation story, where legacy commodity operations are successfully leveraged to fund high-growth industrial greenfield ventures. Successful execution in the biofuel segment holds the key to the stock's long-term valuation trajectory.

High Performance Trading with SAHI.